Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model

Environmental Health Perspectives

Volumn 106, Issue 9, 1998, Pages 581-586

  Hopert, Anne Christine ^a   Bayer, Antje ^a   Frank, Kirsten ^a   Strunck, Elisabeth ^a   Wünsche, Winfried ^a   Vollmer, Günter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Binding affinity; Complement C3; Endometrium; Estrogen receptor; Extracellular matrix; Phytoestrogens

Indexed keywords

COMPLEMENT COMPONENT C3; COUMESTROL; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR; GENISTEIN; MANGOSTIN; MESSENGER RNA; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PHYTOESTROGEN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; BINDING AFFINITY; CELL CULTURE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ESTROGEN ACTIVITY; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; FEMALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SCATCHARD PLOT;

ANIMALIA;

EID: 0031762566     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106581     Document Type: Article

References (41)

1. Carlsen E, Giwercman A, Keiding N, Skakkebaek N. Evidence for decreasing sperm quality of semen during past 50 years. Br Med J 305:609-613 (1992).
2. Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 332:281-285 (1995).
3. Fisch H, Goluboff ET, Oison JH. Semen analyses in 1283 men from the United States over a 25-year period: no decline in quality. Steril Fertil 65:1009-1114 (1996).
4. Devis DL, Bradlow HL, Wolff M, Woodruff T, Hoal DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
5. Davis DL, Telang NT, Osborne MP, Bradlow HL. Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancer. Environ Health Perspect 105(suppl 3):571-576 (1997).
6. Mittendorf R. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstillbestrol (DES) in utero. Teratology 51:435-445 (1995).
7. Boyd J, Takahashi H, Waggoner SE, Jones LA, Hajek RA, Wharton JT, Liu FS, Fujino T, Barren JC, McLachlan JA. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstillbestrol exposure in utero. Cancer 77:507-513 (1996).
8. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103(suppl 7):103-112 (1995).
9. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson J-A. Comparison of the ligand binding specifity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870 (1997).
10. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 45:399-405 (1993).
11. Tang BY, Adams NR. Effect of equol on oestrogen receptors and on synthesis of DNA and protein in the immature rat uterus. J Endocrinol 85:291-297 (1980).
12. Folman Y, Pope GS. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 34:215-225 (1965).
13. Schütze N, Kraft V, Deerberg F, Winking H, Meitinger D, Ebert K, Knuppen R, Vollmer G. Functions of estrogens and anti-estrogens in the rat endomethal adenocarcinoma cell lines RUCA-I and RUCA-II. Int J Cancer 52:941-949 (1992).
14. Vollmer G, Hopert A-C, Ellerbrake N, Wünsche W, Knuppen R, Fibronectin is an estrogen-repressed protein in RUCA-I rat endometrial adenocarcinoma cells, J Steroid Biochem Mol Biol 54:131-139 (1995b).
15. Vollmer G, Ellerbrake N, Hopert A-C, Knauthe R, Wünsche W, Knuppen R. Extracellular matrix induces hormone responsiveness and differentiation in RUCA-I rat endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 52:259-269 (1995a).
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:660-685 (1970).
17. Vollmer G, Wünsche W, Schütze N, Feit B, Knuppen R. Methyl and bromo derivatives of estradiol are agonistic ligands for the estrogen receptor of MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 39:359-366 (1991).
18. Schütze N, Vollmer G, Wünsche W, Grote A, Feit B, Knuppen R. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to the estrogen receptor in cytosolic extracts and nuclei of intact cells. Exp Clin Endocrinol 102:399-408 (1994).
19. E.O.R.T.C, Group. BCC. Standards for the assessment of estrogen receptors in human breast cancer. Eur J Cancer 9:379-381 (1973).
20. Sundstrom SA, Komm BS, Ponce-de Leon H, Yi Z, Teuscher C, Lyttle R. Estrogen regulation of tissue-specific expression of complement C3. J Biol Chem 264:16,941-16,947 (1989).
21. Kuivanen PC, Capulong RB, Harkins RN, Desombre ER. The estrogen-responsive 110 K and 74 K uterine secretory proteins are structurally related to complement C3. Biochem Biophys Res Commun 158:898-905 (1989).
22. Hyder SM, Shipley GL, Stancel GM. Estrogen action in target cells: selective requirements for activation of different hormone response elements. Mol Cell Endocrinol 112:35-43 (1995).
23. Vollmer G, Schneider MR. The rat endometrlal adenocarcinoma cell line RUCA-I: a novel hormone-responsive in vivo/in vitro tumor model. J Steroid Biochem Mol Biol 58:103-115 (1996).
24. Jordan VC. Tamoxifen treatment for breast cancer: concept to gold standard, Oncol Huntingt 11S1:7-13 (1997).
25. Sarkaria JN, Gibson DP, Jordan VC, Fowler JF, Lindstrom MJ, Mulcahy RT. Tamoxifen-induced increase in the potential doubling. Cancer Res 53:4413-4417 (1993).
26. Jordan VC, Gottardis MM, Satyaswaroop PG. Tamoxifen-stimulated growth of human endomethal carcinoma. Ann NY Acad Sci 622:439-446 (1991).
27. Gottardis MM, Ricchio ME, Satyaswaroop PG, Jordan VC. Effect of steroidal and nonsteroidal anti-estrogens on growth of a temoxifen-stimulated human endometrial carcinoma (EnCa1O1) an athymic mice. Cancer Res 50:3189-3192 (1990).
28. Wünsche W, Tenniswood MP, Schneider MR, Vollmer G. Estrogenic regulation of clusterin mRNA in normal and malignant endometrial tissue. Int J Cancer 76:684-688 (1998).
29. Whitten PL, Russel E, Naftolin F. Effects of a normal, human-concentration, phytoestrogen diet on rat uterine growth. Steroids 57:98-106 (1992).
30. Miksicek RJ. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49:153-160 (1994).
31. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y, Genistein, a specific inhibitor of tyrosine-specific protein kinases, J Biol Chem 262:5592-5595 (1987).
32. Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on growth of (Val 12) Ha-ras-transformed NIH 3T3 cells. Biocham Biophys Res Commun 157:183-189 (1988).
33. O'Malley BW, Schrader WT, Mani S, Smith C, Weigsl N, Conneely O, Clark JH. An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog Norm Res 50:333-347 (1995).
34. Ignar-Trowbridge DM, Pimentel M, Teng CT, Korach KS, Lachlan JA. Cross talk between peptide growth factor and estrogen receptor signaling systems. Environ Health Perspect 103 (suppl 7):35-38 (1995).
35. Whitten PL, Lewis C, Russel E, Naftolin F. Potential adverse effects of phytoestrogens. J Nutr 125 S3:771-776 (1995).
36. Whitten PL, Naftolin F. Dietary estrogens - a biologically active background for estrogen action. In: New Biology of Steroid Hormones, Serono Symposia, Vol 74 (Hochberg RB, Naftolin F, eds). New York:Raven Press, 1991:155-167.
37. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50 S201:3-23 (1990).
38. Loukovaara M, Carson M, Adlercreutz H. Regulation of sex-hormone-binding globulin production by endogenous estrogens in vitro. Biochem Biophys Res Commun 206:895-901 (1995).
39. Loukovaara M, Carson M, Palotie A, Adlercreutz H. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids 60:656-661 (1995).
40. Markaverich BM, Webb B, Densmore CL, Gregory RR. Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. Environ Health Perspect 103:574-581 (1995).
41. Lyn-Cook BD, Blann E, Payne PW, Bo J, Sheehan D, Medlock K. Methylation profile and amplification of proto-oncogenes in rat pancreas induced with phytoestrogens. Proc Soc Exp Biol Med 208:116-119 (1995).